跳至主要内容
临床试验/NCT05952544
NCT05952544已完成不适用

Does Protein Restriction Plus Essential Amino Acids and Keto-analogues Supplementation Have a Beneficial Effect on GFR Decline in CKD Patients?

Alexandria University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2023年7月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
GFR decline

研究概览

简要总结

This study aims to investigate the effect of protein restriction plus KA/EAA supplementation on GFR decline in CKD patients.

详细描述

In chronic kidney disease (CKD) patients, ketoacid analogues of essential amino acids (KA/EAA) are administered to reduce the production of harmful metabolic products and enhance nutritional status. Protein restriction combined with AA supplement may have beneficial effects on CKD in several ways, by reducing nitrogen waste, oxidative stress, and inflammation, and by protecting against hemodynamic changes in glomerular hyperfiltration.

several clinical trials have documented that very low protein diets (VLPD) supplemented with KA/EAA preserve the rate of progression of advanced CKD. However, in long-term follow-up of the MDRD study, VLPD plus KA/EAA treatment did not delay progression to dialysis or transplantation.

As a result, no firm conclusions have been drawn on the effectiveness of protein-restricted diets combined with KA/EAA supplements in retarding CKD progression.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with CKD stages (G2 to G4), aged ≥ 18 years old

排除标准

  • Active malignancy
  • Protein energy wasting
  • Advanced organ disease

研究组 & 干预措施

control group

include patients who were on low protein diet only

干预措施: low protein diet (Other)

interventional group

include patients who consumed KA/EAA plus very low protein diet

干预措施: essential amino acids and keto-analogues supplementation (Drug)

结局指标

主要结局

GFR decline

时间窗: 24 months

effect on GFR change at one year from baseline in CKD patients

次要结局

  • effect on calcium(24 months)
  • effect on albumin(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Mamdouh Mahmoud Mohamed Elsayed , MD

Lecturer

Alexandria University

研究点 (1)

Loading locations...

相似试验